Tenet Healthcare Beats Peers in Q2, Still Trades at 12x Earnings

NEW YORK, August 5, Tenet Healthcare Corporation (THC) ranked first among hospital chain peers, ahead of HCA Healthcare, Community Health Systems, and Universal Health Services, in Q2 2026 earnings season, while still trading at a 9.7x trailing P/E. That is an unusual combination: the top-ranked operator in a sector at a sub-10x multiple on trailing earnings.

Ranking Above HCA, Community Health, and Universal Health Means the Operating Model Held

Topping a peer group that includes HCA Healthcare, Community Health Systems, and Universal Health Services is not a consensus beat, it is a relative operating verdict. All four chains faced the same labor cost environment, the same reimbursement calendar, and the same macro backdrop in Q2 2026. THC came out ahead of that field on the earnings scorecard. The wire story leads with that rank; the detail that receives less attention is what the underlying financials imply about valuation.

TTM revenue of $21.8bn grew 6.8% year-over-year. Free cash flow landed at $2.2bn. Trailing EPS of $26.22 against a share price of $253.33 implies a trailing P/E of roughly 9.7x, below the already-modest 12.3x forward figure the market is assigning. For the operator that just outranked HCA, Community Health, and Universal Health in the same quarter, a sub-10x trailing multiple is a signal worth interrogating.

$2.2bn in FCF Is the Number the Peer-Rank Headline Buries

A peer-group ranking tells you about relative performance; free cash flow tells you about capital generation. At $2.2bn on a $21.8bn revenue base, THC is producing cash at a rate the current multiple does not obviously reflect. The 90-day chart, with the Q2 earnings event marked, shows where the $253.33 share price sits against recent history and how much of the Q2 beat has actually been priced in.

The Missing Data Still Matters

The peer-group rank and headline valuation are confirmed. What is not available in the Q2 inputs: same-hospital volume trends and adjusted EBITDA margin detail. Hospital chain earnings can look clean on revenue while absorbing labor cost pressure that surfaces only at the margin line. A 12.3x forward P/E assumes the earnings trajectory holds; any Q3 guidance cut on same-hospital revenue growth or adjusted EBITDA margin closes the gap between "cheap" and "value trap" quickly. A low multiple on a top performer is durable only if the cost structure holds, that answer arrives with Q3 results.

For context on how to read between the lines of a quarterly filing, see the guide on how to read an earnings report.

Bottom Line

This is a value investor's setup after Q2, not a momentum trade. The top-ranked operator among HCA, Community Health Systems, and Universal Health Services in Q2 2026 is trading at a sub-10x trailing multiple with $2.2bn in FCF, that combination is uncommon in healthcare. Run the $2.2bn FCF base through the DCF calculator to stress-test what "cheap" actually holds at different growth assumptions before calling this a buy. The one number to watch next quarter: same-hospital revenue growth. If it is positive and adjusted EBITDA margins hold, the 12.3x forward P/E looks like a persistent mismatch the market is slow to close. If margins compress, the peer-group rank becomes historical color. For the full fundamentals and a generated equity report, visit the Tenet Healthcare stock page on Basis Report.

Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.

Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.